ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

WGS vs AVAH // EV/EBITDA & P/E VALUATION

GeneDx Holdings Corp. (Class A) (NASDAQ) VS. Aveanna Healthcare Holdings Inc. (NASDAQ) • 15-METRIC TALLY: WGS 3 — AVAH 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WGS VS. AVAH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC WGS AVAH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 69.70% 33.30% +36.40 WGS /gross-margins <GO>
Return on Invested Capital (ROIC) -4.10% 15.70% -19.80 AVAH /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 15.5x — TIE /valuation <GO>
Free Cash Flow Yield 0.67% 4.35% -3.68 AVAH /fcf-yield <GO>
Operating Margin -3.10% 10.50% -13.60 AVAH /operating-margins <GO>
Net Profit Margin -4.90% 0.00% -4.90 AVAH /net-margins <GO>
Revenue Growth (YoY) 40.00% 20.20% +19.80 WGS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.32 1.86 +1.46 WGS /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.5 56.0 -7.51 AVAH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.12B $2.89B -$775.6M AVAH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR WGS REV AVAH REV WGS GROSS % AVAH GROSS % WGS FCF AVAH FCF
FY 2025 $427.5M $2.43B 69.7% 33.3% $14.3M $125.9M
FY 2024 $305.4M $2.02B 63.6% 31.4% -$34.0M $32.6M
FY 2023 $202.6M $1.90B — — -$180.1M $22.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WGS // BETA —
AVAH // BETA —